Literature DB >> 8396684

Divergence between cytotoxic effector function and tumor necrosis factor alpha production for inflammatory CD4+ T cells from mice with Sendai virus pneumonia.

S Hou1, M Fishman, K G Murti, P C Doherty.   

Abstract

Sendai virus pneumonia in beta 2-microglobulin-deficient [beta 2-m(-/-)] mice lacking CD8+ T cells is characterized by the development of CD4+ cytotoxic T lymphocytes that can be recovered directly from the respiratory tract. These CD4+ cytotoxic T lymphocytes are not found in beta 2-m (+/+) mice, though inflammatory CD4+ T cells from both beta 2-m (-/-) and beta 2-m (+/+) mice produce substantial amounts of tumor necrosis factor alpha. Blocking experiments with a monoclonal antibody that also inhibits tumor necrosis factor beta show that the secreted forms of these two cytokines are not responsible for virus-specific killing of class II major histocompatibility complex-compatible targets. Comparison of electron micrographs indicates that the CD4+ effectors from the beta 2-m (-/-) mice are potent inducers of apoptosis, while this is not the case for the beta 2-m (+/+) CD4+ set. These experiments further define the functional status of virus-specific CD4+ T cells responding in vivo in the presence or absence of CD8+ effectors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396684      PMCID: PMC238057     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

Review 1.  Cell-mediated cytotoxicity: contact and secreted factors.

Authors:  S Apasov; F Redegeld; M Sitkovsky
Journal:  Curr Opin Immunol       Date:  1993-06       Impact factor: 7.486

2.  Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.

Authors:  K C Sheehan; N H Ruddle; R D Schreiber
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

3.  Features of target cell lysis by class I and class II MHC-restricted cytolytic T lymphocytes.

Authors:  M M Maimone; L A Morrison; V L Braciale; T J Braciale
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

4.  Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells.

Authors:  W Allan; Z Tabi; A Cleary; P C Doherty
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

5.  Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.

Authors:  M Zijlstra; M Bix; N E Simister; J M Loring; D H Raulet; R Jaenisch
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

6.  Localization of adenovirus-encoded DNA replication proteins in the nucleus by immunogold electron microscopy.

Authors:  K G Murti; D S Davis; G R Kitchingman
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

7.  Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.

Authors:  P A Scherle; G Palladino; W Gerhard
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

8.  Cytolytic activities of activated macrophages versus paraformaldehyde-fixed macrophages; soluble versus membrane-associated TNF.

Authors:  M Fishman
Journal:  Cell Immunol       Date:  1991-10-01       Impact factor: 4.868

9.  An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.

Authors:  N H Ruddle; C M Bergman; K M McGrath; E G Lingenheld; M L Grunnet; S J Padula; R B Clark
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

10.  Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells.

Authors:  M Eichelberger; W Allan; M Zijlstra; R Jaenisch; P C Doherty
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  11 in total

1.  CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus.

Authors:  Stephen A Stohlman; David R Hinton; Beatriz Parra; Roscoe Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 2.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

3.  Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection.

Authors:  A J Zajac; D G Quinn; P L Cohen; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium.

Authors:  D J Topham; R A Tripp; S R Sarawar; M Y Sangster; P C Doherty
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

5.  Role of CD8 T cells in primary Chlamydia infection.

Authors:  D M Magee; D M Williams; J G Smith; C A Bleicker; B G Grubbs; J Schachter; R G Rank
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

6.  Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis.

Authors:  Carine Savarin; Cornelia C Bergmann; David R Hinton; Richard M Ransohoff; Stephen A Stohlman
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

7.  Circulating immunoglobulin G can play a critical role in clearance of intestinal reovirus infection.

Authors:  M L Barkon; B L Haller; H W Virgin
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68.

Authors:  K E Weck; M L Barkon; L I Yoo; S H Speck; I V Virgin HW
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

Review 9.  Cytotoxic CD4 T cells in antiviral immunity.

Authors:  Nikki B Marshall; Susan L Swain
Journal:  J Biomed Biotechnol       Date:  2011-11-22

Review 10.  CD4 memory T cells: what are they and what can they do?

Authors:  Megan K L MacLeod; Eric T Clambey; John W Kappler; Philippa Marrack
Journal:  Semin Immunol       Date:  2009-03-09       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.